ICON has announced financial results for the 1st quarter 2016. Full consolidated income statements and summary balance sheet data can be read here
Some of the highlights from the first quarter include:
• ICON’s selection by Genomics England to support the world’s largest genome sequencing project for cancer and rare diseases– the 100K genomes project aims to create a new genomic medicine service for the NHS to support better diagnosis and more personalised treatments for patients.
• ICON’s selection by the International Consortium for Health Outcomes Measurement to create the world’s first global healthcare outcomes benchmarking programme– the programme will enable healthcare providers to compare their patients’ outcomes to those of their global peers and identify opportunities to improve outcomes and/or lower costs while maintaining outcomes.
ICON currently operates from 89 locations in 37 countries and has approximately 12,200 employees.